1 of 8
Alzheimer's Association
Maria C. Carrillo, PhD, chief science officer for the Alzheimer’s Association
2 of 8
Alzheimer's Association
3 of 8
Alzheimer's Association
Chicago’s McCormick Place, the largest convention center in North America
4 of 8
Alzheimer's Association
5 of 8
Alzheimer's Association
6 of 8
Alzheimer's Association
7 of 8
Alzheimer's Association
8 of 8
Alzheimer's Association
Bringing the world closer to breakthroughs in dementia science, more than 5,100 leading experts and researchers from around the world gathered in Chicago for the Alzheimer’s Association International Conference (AAIC) 2018 in Chicago.
The first randomized clinical trial to demonstrate that intensive blood pressure treatment reduces new cases of mild cognitive impairment (MCI), and the combined risk of MCI plus all-cause dementia, was the highlight of new research results reported at the event.
AAIC 2018 also featured several “firsts,” including the first-ever study evaluating dementia prevalence in a large population of lesbian, gay and bisexual (LGB) older adults and the first large-scale study of reproductive history and dementia risk in women.
“The exciting data from innovative research studies reported at AAIC 2018 give us many reasons to be hopeful,” said Maria C. Carrillo, PhD, Alzheimer's Association chief science officer.
AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer's and dementia research. This was the largest AAIC in history with nearly 6,000 attendees representing close to 70 countries.